Population Estimates of Sickle Cell Disease in the U.S.

American Journal of Preventive Medicine - Tập 38 - Trang S512-S521 - 2010
Kathryn L. Hassell1
1Colorado Sickle Cell Treatment and Research Center, University of Colorado Denver Health Sciences Center, Aurora, Colorado

Tài liệu tham khảo

Lukens, 1981, Sickle cell disease, Dis Mon, 27, 1, 10.1016/S0011-5029(81)80007-7 1993 Strouse, 2009, The excess burden of stroke in hospitalized adults with sickle cell disease, Am J Hematol, 84, 548, 10.1002/ajh.21476 Kauf, 2009, The cost of health care for children and adults with sickle cell disease, Am J Hematol, 84, 323, 10.1002/ajh.21408 Therrell, 2006, National evaluation of U.S. newborn screening system components, MRDD Research Reviews, 12, 236 Lorey, 1996, Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state, Genetic Epidemiol, 13, 501, 10.1002/(SICI)1098-2272(1996)13:5<501::AID-GEPI6>3.0.CO;2-4 Michlitsch, 2009, Newborn screening for hemoglobinopathies in California, Pediatr Blood Cancer, 52, 486, 10.1002/pbc.21883 Platt, 1994, Mortality in sickle cell disease, NEJM, 330, 1639, 10.1056/NEJM199406093302303 Quinn, 2004, Survival of children with sickle cell disease, Blood, 103, 4023, 10.1182/blood-2003-11-3758 Telfer, 2007, Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London, Haematologica, 92, 905, 10.3324/haematol.10937 King, 2007, Newborn sickle cell disease screening: the Jamaican experience (1995–2006), J Med Screen, 14, 117, 10.1258/096914107782066185 Wierenga, 2001, Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study, Lancet, 357, 680, 10.1016/S0140-6736(00)04132-5 Serjeant, 2009, The changing face of homozygous sickle cell disease: 102 patients over 60 years, Int J Lab Hem, 31, 585, 10.1111/j.1751-553X.2008.01089.x Gaston, 1986, Prophylaxis with oral penicillin in children with sickle cell anemia, NEJM, 314, 1593, 10.1056/NEJM198606193142501 Steinberg, 2003, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment, JAMA, 289, 1645, 10.1001/jama.289.13.1645 Ashley-Koch, 2000, Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review, Am J Epidemiol, 151, 839, 10.1093/oxfordjournals.aje.a010288